The new law reauthorizes fees charged to drug and device makers, creates new fees for the approval of generic drugs.
Daily News Roundup
The new law reauthorizes fees charged to drug and device makers, creates new fees for the approval of generic drugs.
According to a new report, the US Fish and Wildlife Service ignored science advisors and shrunk protected habitats for endangered species from 2002 to 2007.
The United Kingdom's Wellcome Trust announces that it will begin sanctioning researchers who do not submit manuscripts to the public UK PubMed Central database.
Wales creates a database of DNA barcodes for all of its native flowering plants, hoping to guide conservation and drug development efforts.
An advisory committee urges the federal funding agency to take steps to counter racial bias in the granting process.
A public interest legal group has renewed the fight against DNA patenting.
The UK government releases its recommendation that open access be “the main vehicle for the publication of research,” though it warns of the costs that could entail.
Researchers pull viable cells from bodies that had been dead for more than 2 weeks.
The Senate approves an increase of about 0.3 percent for the 2013 NIH budget, but the Department of Energy doesn’t fare as well.
A United Kingdom ethics council approves altering human egg cells, which could allow doctors to correct mitochondrial disease in IVF patients.